We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Positive Control Developed for Serological Tests for Onchocerciasis

By LabMedica International staff writers
Posted on 03 Feb 2016
Print article
Image: The SD BIOLINE Onchocerciasis IgG4 rapid test preproduction prototype (Photo courtesy of  PATH/Dunia Faulx).
Image: The SD BIOLINE Onchocerciasis IgG4 rapid test preproduction prototype (Photo courtesy of PATH/Dunia Faulx).
Onchocerciasis, or “river blindness,” is a disease caused by the filarial parasite Onchocerca volvulus (Ov) that affects an estimated 37 million in Africa and a few thousand people in the Americas and Yemen.

Active infection is detected by direct observation of the Ov microfilariae (MF) through skin snip combined with microscopy, but this method is not very sensitive, especially when microfilarial (MF) skin densities are low, which are typical in low-transmission settings.

Serological assays for human immunoglobulin G4 (IgG) to the O. volvulus antigen Ov16 have been used to confirm elimination of onchocerciasis in much of the Americas and parts of Africa Scientists working at the Diagnostics Global Program (PATH; Seattle, WA; USA) and their international colleagues have standardized a source of positive control antibody (human anti-Ov16 IgG4) that will ensure the quality of surveillance data using these tests.

A recombinant human IgG4 antibody to Ov16 was identified by screening against a synthetic human Fab phage display library and converted into human IgG4. This antibody was developed into different positive control formulations for enzyme-linked immunosorbent assay (ELISA) and rapid diagnostic test (RDT) platforms. Variation in ELISA results and utility as a positive control of the antibody were assessed from multiple laboratories.

When the anti-Ov16 IgG4 antibody was used as a standard dilution in horseradish peroxidase (HRP) and alkaline phosphatase (AP) ELISAs, the detection limits were approximately 1ng/mL by HRP ELISA and 10ng/mL by AP ELISA. Positive control dilutions and spiked dried blood spots (DBS) produced similar ELISA results. Used as a simple plate normalization control, the positive control antibody may improve ELISA data comparison in the context of inter-laboratory variation.

The authors concluded that the recombinant human anti-Ov16 IgG4 antibody-based positive control will benefit inter-laboratory validation of ELISA assays and serve as quality control (QC) reagents for Ov16 RDTs at different points of the supply chain from manufacturer to field use. With the availability of an Ov16 RDT (SD BIOLINE Onchocerciasis IgG4 test; Alere, Standard Diagnostics, Inc.; Yongin, Republic of Korea; www.standardia.com), the ability to monitor the quality of an RDT outside the context of a laboratory throughout the lifecycle of the test in shipping, storage, and use is paramount to having reliable results. The study was published on January 8, 2016, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Diagnostics Global Program
Standard Diagnostics, Inc.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.